(Q45878146)

17 December 2017

title

Treatments for muscular dystrophy: increased treatment options for Duchenne and related muscular dystropies (English)

1 reference

17 December 2017

1 reference

1

1 reference

17 December 2017

publication date

5 June 2008

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

issue

15

1 reference

17 December 2017

page(s)

1077-1078

1 reference

17 December 2017

Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.97

Genetic modifiers of muscular dystrophy: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.97

Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.97

Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.97

Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.97

New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.97

inferred from DOI database lookup

7 January 2021

based on heuristic

Genetic treatments in muscular dystrophies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.97

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2008.97

1 reference

17 December 2017

Dimensions Publication ID

1008193489

0 references

1 reference

17 December 2017